News
LH
370.78
+0.69%
2.54
Centene Corp. Stock Falls 7.0%, Underperforms Peers
Dow Jones · 11h ago
OTraces Selects Labcorp To Perform Reference Laboratory Testing For Florida Department Of Health–Funded Clinical Trial Evaluating OTraces Blood-Based Prostate Cancer Diagnostic Platform
Benzinga · 19h ago
Labcorp announces collaboration with Brazilian Grupo Fleury
TipRanks · 1d ago
Labcorp Collaborates With Grupo Fleury To Expand Clinical Trial Operations In Brazil
Benzinga · 1d ago
Mizuho Securities Remains a Buy on Labcorp Holdings (LH)
TipRanks · 2d ago
OPKO Slips To Loss In Q3 On Impact Of Discontinued Operations, Revenue Up
NASDAQ · 2d ago
Weekly Report: what happened at LH last week (1109-1113)?
Weekly Report · 2d ago
Labcorp Earnings Call Signals Growth Despite PAMA Risks
TipRanks · 4d ago
Can Labcorp Holdings (LH) Hold Its Value After The $375 Million Deal?
Simply Wall St · 4d ago
Labcorp: 3 Key Takeaways for Long-Term Investors
The Motley Fool · 6d ago
Weekly Report: what happened at LH last week (1102-1106)?
Weekly Report · 11/09 09:37
Why Labcorp Holdings (LH) Is Back In The Spotlight
Simply Wall St · 11/08 22:20
What Labcorp Holdings Shares Earnings Beat Means For Shareholders
Simply Wall St · 11/07 18:29
Centene Corp. Stock Slips 6.0%, Underperforms Peers
Dow Jones · 11/06 21:35
Charles River Laboratories International Inc. Stock Climbs 7.8%, Outperforms Peers
Dow Jones · 11/06 21:34
Labcorp raised to Buy at HSBC on M&A and diagnostics momentum
Seeking Alpha · 11/05 15:10
Labcorp upgraded to Buy from Hold at HSBC
TipRanks · 11/05 10:15
Centene Corp. Stock Rises 12.6%, Outperforms Peers
Dow Jones · 11/04 21:34
Labcorp Announces CFO Participation in UBS Healthcare Conference
TipRanks · 11/04 14:50
Labcorp to Speak at the UBS Global Healthcare Conference
PR Newswire · 11/04 13:00
More
Webull provides a variety of real-time LH stock news. You can receive the latest news about Labcorp Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About LH
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.